ORMP Competitors
Oramed Pharmaceuticals Inc.
$4.14
-$0.03(-0.72%)
50
Overall
80
Value
27
Tech
44
Quality
Market Cap
$173.46M
Volume
146.55K
52W Range
$2.09 - $5.47
Target Price
$7.00
ORMP competitors: RARE, CGEN, SNY, NVO, LXRX. Oramed Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ORMP Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical Inc. | $14.90 | $1.47B | $-3.95 | - | 33 |
| CGEN Compugen Ltd. | $2.00 | $189.17M | $-0.28 | - | 48 |
| SNY Sanofi | $39.77 | $95.41B | $5.00 | 6.08% | 60 |
| NVO Novo Nordisk A/S | $38.12 | $168.79B | $3.53 | 4.86% | 47 |
| LXRX Lexicon Pharmaceuticals, Inc. | $1.60 | $711.93M | $-0.17 | - | 38 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORMP | $4.14 | -0.7% | 146.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW